Karyopharm Therapeutics Inc. - Common Stock — キャッシュフロー (NASDAQ:KPTI) | MetaTrader

チャート全体を表示 Full chart

Financials

概要明細書統計

営業活動によるキャッシュフロー -160.23 M-107.12 M-149.55 M-92.72 M-127.49 M-75.37 M -59.11 M 投資活動によるキャッシュフロー -53.69 M141.84 M-104.26 M7.94 M95.47 M43.38 M 31.29 M 財務活動によるキャッシュフロー 172.08 M73.65 M193.74 M1.12 M41.65 M30.05 M 79.85 M フリーキャッシュフロー -160.23 M-107.12 M-149.55 M-92.72 M-127.49 M-75.37 M -59.11 M

ニュース

Wall Street Analysts Think Karyopharm Therapeutics (KPTI) Could Surge 70.46%: Read This Before Placing a Bet

Karyopharm Therapeutics (KPTI) Reports Q1 Loss, Beats Revenue Estimates

Verrica Pharmaceuticals Inc. (VRCA) Reports Q1 Loss, Tops Revenue Estimates

Karyopharm Therapeutics (KPTI) Stock Jumps 6.9%: Will It Continue to Soar?

Karyopharm: Putting The Phase 3 Trial In Context (NASDAQ:KPTI)

KPTI Stock Down on Mixed Phase III Myelofibrosis Combo Study Data

Assertio (ASRT) Surges 17.9%: Is This an Indication of Further Gains?

Karyopharm Therapeutics Inc. (KPTI) Discusses Top Line Results From Phase III SENTRY Trial in Myelofibrosis - Slideshow (NASDAQ:KPTI) 2026-03-25

Karyopharm Therapeutics Inc. (KPTI) Discusses Top Line Results From Phase III SENTRY Trial in Myelofibrosis Transcript

Why Is Karyopharm Therapeutics Stock Trading Lower Today? - Karyopharm Therapeutics (NASDAQ:KPTI)

Rodman & Renshawが Karyopharm株を買い推奨でカバレッジ開始

Rodman & Renshaw initiates Karyopharm stock with buy rating